{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:28:52Z","timestamp":1792790932533,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32 DK007053-44"],"award-info":[{"award-number":["T32 DK007053-44"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA175382"],"award-info":[{"award-number":["R01CA175382"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA175382"],"award-info":[{"award-number":["R01CA175382"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM086308-06A1"],"award-info":[{"award-number":["GM086308-06A1"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32 HL007224-40"],"award-info":[{"award-number":["T32 HL007224-40"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/012pb6c26","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL132325"],"award-info":[{"award-number":["R01 HL132325"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/012pb6c26","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","id":[{"id":"https:\/\/ror.org\/012pb6c26","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008637","name":"Center for Strategic Scientific Initiatives, National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA191970"],"award-info":[{"award-number":["R21CA191970"]}],"id":[{"id":"10.13039\/100008637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008637","name":"Center for Strategic Scientific Initiatives, National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA193958"],"award-info":[{"award-number":["R21CA193958"]}],"id":[{"id":"10.13039\/100008637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Casitas B lymphoma (c-Cbl) is an E3 ubiquitin ligase and a negative regulator of colorectal cancer (CRC). Despite its high expression in immune cells, the effect of c-Cbl on the tumor microenvironment remains poorly understood. Here we demonstrate that c-Cbl alters the tumor microenvironment and suppresses Programmed cell death-1 (PD-1) protein, an immune checkpoint receptor. Using syngeneic CRC xenografts, we observed significantly higher growth of xenografts and infiltrating immune cells in c-Cbl\n                    <jats:sup>+\/\u2212<\/jats:sup>\n                    compared to c-Cbl\n                    <jats:sup>\n                      <jats:bold>+\/+<\/jats:bold>\n                    <\/jats:sup>\n                    mice. Tumor-associated CD8+ T-lymphocytes and macrophages of c-Cbl\n                    <jats:sup>+\/\u2212<\/jats:sup>\n                    mice showed 2\u20133-fold higher levels of PD-1. Functionally, macrophages from c-Cbl\n                    <jats:sup>+\/\u2212<\/jats:sup>\n                    mice showed a 4\u20135-fold reduction in tumor phagocytosis, which was restored with an anti-PD-1 neutralizing antibody suggesting regulation of PD-1 by c-Cbl. Further mechanistic probing revealed that C-terminus of c-Cbl interacted with the cytoplasmic tail of PD-1. c-Cbl destabilized PD-1 through ubiquitination- proteasomal degradation depending on c-Cbl\u2019s RING finger function. This data demonstrates c-Cbl as an E3 ligase of PD-1 and a regulator of tumor microenvironment, both of which were unrecognized components of its tumor suppressive activity. Advancing immune checkpoint and c-Cbl biology, our study prompts for probing of PD-1 regulation by c-Cbl in conditions driven by immune checkpoint abnormalities such as cancers and autoimmune diseases.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-56208-1","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T06:02:42Z","timestamp":1577426562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["c-Cbl targets PD-1 in immune cells for proteasomal degradation and modulates colorectal tumor growth"],"prefix":"10.1038","volume":"9","author":[{"given":"Chimera","family":"Lyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6791-4531","authenticated-orcid":false,"given":"Kei","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Arthur","family":"Napoleon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nkiruka","family":"Arinze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2097-6882","authenticated-orcid":false,"given":"Mostafa","family":"Belghasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irva","family":"Vellard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8123-4228","authenticated-orcid":false,"given":"Wenqing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Ravid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Zavaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razie","family":"Amraei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Phatak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Rifkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6663-6058","authenticated-orcid":false,"given":"Vipul C.","family":"Chitalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,27]]},"reference":[{"key":"56208_CR1","doi-asserted-by":"publisher","unstructured":"Siegel, R. L. et al. Colorectal Cancer Incidence Patterns in the United States, 1974\u20132013. J Natl Cancer Inst 109, https:\/\/doi.org\/10.1093\/jnci\/djw322 (2017).","DOI":"10.1093\/jnci\/djw322"},{"key":"56208_CR2","doi-asserted-by":"crossref","unstructured":"Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759\u2013767, 0092-8674(90)90186-I (1990).","DOI":"10.1016\/0092-8674(90)90186-I"},{"key":"56208_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/3506710035067100","volume":"2","author":"CB Thien","year":"2001","unstructured":"Thien, C. B. & Langdon, W. Y. Cbl: many adaptations to regulate protein tyrosine kinases. Nat Rev Mol Cell Biol 2, 294\u2013307, https:\/\/doi.org\/10.1038\/3506710035067100 (2001).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"56208_CR4","doi-asserted-by":"crossref","unstructured":"Schmidt, M. H. & Dikic, I. The Cbl interactome and its functions. Nat Rev Mol Cell Biol 6, 907\u2013918, nrm1762 10.1038\/nrm1762 (2005).","DOI":"10.1038\/nrm1762"},{"key":"56208_CR5","doi-asserted-by":"publisher","first-page":"15547","DOI":"10.1073\/pnas.95.26.15547","volume":"95","author":"M Naramura","year":"1998","unstructured":"Naramura, M., Kole, H. K., Hu, R. J. & Gu, H. Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc Natl Acad Sci USA 95, 15547\u201315552 (1998).","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"56208_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/cells8050498","volume":"8","author":"Chimera L. Lyle","year":"2019","unstructured":"Lyle, C. L., Belghasem, M. & Chitalia, V. C. c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis. Cells 8, https:\/\/doi.org\/10.3390\/cells8050498 (2019).","journal-title":"Cells"},{"key":"56208_CR7","doi-asserted-by":"publisher","first-page":"12537","DOI":"10.1074\/jbc.M114.616623","volume":"290","author":"S Shivanna","year":"2015","unstructured":"Shivanna, S. et al. The c-Cbl ubiquitin ligase regulates nuclear beta-catenin and angiogenesis by its tyrosine phosphorylation mediated through the Wnt signaling pathway. J Biol Chem 290, 12537\u201312546, https:\/\/doi.org\/10.1074\/jbc.M114.616623 (2015).","journal-title":"J Biol Chem"},{"key":"56208_CR8","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.1073\/pnas.0700809104","volume":"104","author":"AJ Singh","year":"2007","unstructured":"Singh, A. J. et al. A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis. Proc Natl Acad Sci USA 104, 5413\u20135418, https:\/\/doi.org\/10.1073\/pnas.0700809104 (2007).","journal-title":"Proc Natl Acad Sci USA"},{"key":"56208_CR9","doi-asserted-by":"publisher","first-page":"71136","DOI":"10.18632\/oncotarget.12107","volume":"7","author":"M Shashar","year":"2016","unstructured":"Shashar, M. et al. c-Cbl mediates the degradation of tumorigenic nuclear beta-catenin contributing to the heterogeneity in Wnt activity in colorectal tumors. Oncotarget 7, 71136\u201371150, https:\/\/doi.org\/10.18632\/oncotarget.12107 (2016).","journal-title":"Oncotarget"},{"key":"56208_CR10","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.ajpath.2018.05.007","volume":"188","author":"S Kumaradevan","year":"2018","unstructured":"Kumaradevan, S. et al. c-Cbl Expression Correlates with Human Colorectal Cancer Survival and Its Wnt\/beta-Catenin Suppressor Function Is Regulated by Tyr371 Phosphorylation. Am J Pathol 188, 1921\u20131933, https:\/\/doi.org\/10.1016\/j.ajpath.2018.05.007 (2018).","journal-title":"Am J Pathol"},{"key":"56208_CR11","doi-asserted-by":"publisher","first-page":"23505","DOI":"10.1074\/jbc.M113.473801","volume":"288","author":"V Chitalia","year":"2013","unstructured":"Chitalia, V. et al. c-Cbl, a ubiquitin E3 ligase that targets active beta-catenin: a novel layer of Wnt signaling regulation. J Biol Chem 288, 23505\u201323517, https:\/\/doi.org\/10.1074\/jbc.M113.473801 (2013).","journal-title":"J Biol Chem"},{"key":"56208_CR12","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/ng.641","volume":"42","author":"CM Niemeyer","year":"2010","unstructured":"Niemeyer, C. M. et al. Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nat Genet 42, 794\u2013800, https:\/\/doi.org\/10.1038\/ng.641 (2010).","journal-title":"Nat Genet"},{"key":"56208_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nri.2017.108","volume":"18","author":"AH Sharpe","year":"2018","unstructured":"Sharpe, A. H. & Pauken, K. E. The diverse functions of the PD1 inhibitory pathway. Nat Rev Immunol 18, 153\u2013167, https:\/\/doi.org\/10.1038\/nri.2017.108 (2018).","journal-title":"Nat Rev Immunol"},{"key":"56208_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon, S. R. et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature 545, 495\u2013499, https:\/\/doi.org\/10.1038\/nature22396 (2017).","journal-title":"Nature"},{"key":"56208_CR15","doi-asserted-by":"publisher","first-page":"5654","DOI":"10.4049\/jimmunol.0803942","volume":"182","author":"BM Dale","year":"2009","unstructured":"Dale, B. M., Traum, D., Erdjument-Bromage, H., Tempst, P. & Greenberg, S. Phagocytosis in macrophages lacking Cbl reveals an unsuspected role for Fc gamma receptor signaling and actin assembly in target binding. J Immunol 182, 5654\u20135662, https:\/\/doi.org\/10.4049\/jimmunol.0803942 (2009).","journal-title":"J Immunol"},{"key":"56208_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fonc.2018.00049","volume":"8","author":"AR Poh","year":"2018","unstructured":"Poh, A. R. & Ernst, M. Targeting Macrophages in Cancer: From Bench to Bedside. Front Oncol 8, 49, https:\/\/doi.org\/10.3389\/fonc.2018.00049 (2018).","journal-title":"Front Oncol"},{"key":"56208_CR17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ccell.2018.10.006","volume":"34","author":"W Wang","year":"2018","unstructured":"Wang, W. et al. RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer. Cancer Cell 34, 757\u2013774 e757, https:\/\/doi.org\/10.1016\/j.ccell.2018.10.006 (2018).","journal-title":"Cancer Cell"},{"key":"56208_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10501","volume":"7","author":"S Koyama","year":"2016","unstructured":"Koyama, S. et al. Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints. Nat Commun 7, 10501, https:\/\/doi.org\/10.1038\/ncomms10501 (2016).","journal-title":"Nat Commun"},{"key":"56208_CR19","doi-asserted-by":"publisher","first-page":"5538","DOI":"10.4049\/jimmunol.169.10.5538","volume":"169","author":"T Yamazaki","year":"2002","unstructured":"Yamazaki, T. et al. Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 169, 5538\u20135545 (2002).","journal-title":"J Immunol"},{"key":"56208_CR20","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/1873-3468.12985","volume":"592","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. E3 ubiquitin ligases Cbl-b and c-Cbl downregulate PD-L1 in EGFR wild-type non-small cell lung cancer. FEBS letters 592, 621\u2013630, https:\/\/doi.org\/10.1002\/1873-3468.12985 (2018).","journal-title":"FEBS letters"},{"key":"56208_CR21","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.3324\/haematol.2018.197194","volume":"103","author":"M Pollari","year":"2018","unstructured":"Pollari, M. et al. PD-L1(+) tumor-associated macrophages and PD-1(+) tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma. Haematologica 103, 1908\u20131914, https:\/\/doi.org\/10.3324\/haematol.2018.197194 (2018).","journal-title":"Haematologica"},{"key":"56208_CR22","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/ncb1781","volume":"10","author":"VC Chitalia","year":"2008","unstructured":"Chitalia, V. C. et al. Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL. Nat Cell Biol 10, 1208\u20131216, https:\/\/doi.org\/10.1038\/ncb1781 (2008).","journal-title":"Nat Cell Biol"},{"key":"56208_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nsmb.2231","volume":"19","author":"H Dou","year":"2012","unstructured":"Dou, H. et al. Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl. Nat Struct Mol Biol 19, 184\u2013192, https:\/\/doi.org\/10.1038\/nsmb.2231 (2012).","journal-title":"Nat Struct Mol Biol"},{"key":"56208_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bbamcr.2012.10.010","volume":"1833","author":"B Mohapatra","year":"2013","unstructured":"Mohapatra, B. et al. Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases. Biochim Biophys Acta 1833, 122\u2013139, https:\/\/doi.org\/10.1016\/j.bbamcr.2012.10.010 (2013).","journal-title":"Biochim Biophys Acta"},{"key":"56208_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ccr.2013.02.013","volume":"23","author":"M De Palma","year":"2013","unstructured":"De Palma, M. & Lewis, C. E. Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 23, 277\u2013286, https:\/\/doi.org\/10.1016\/j.ccr.2013.02.013 (2013).","journal-title":"Cancer Cell"},{"key":"56208_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53463-0","volume":"9","author":"K Bardhan","year":"2019","unstructured":"Bardhan, K. et al. Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells. Sci Rep 9, 17252, https:\/\/doi.org\/10.1038\/s41598-019-53463-0 (2019).","journal-title":"Sci Rep"},{"key":"56208_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-018-0756-0","volume":"564","author":"X Meng","year":"2018","unstructured":"Meng, X. et al. FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells. Nature 564, 130\u2013135, https:\/\/doi.org\/10.1038\/s41586-018-0756-0 (2018).","journal-title":"Nature"},{"key":"56208_CR28","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/sj.onc.1202653","volume":"18","author":"E Latres","year":"1999","unstructured":"Latres, E., Chiaur, D. S. & Pagano, M. The human F box protein beta-Trcp associates with the Cul1\/Skp1 complex and regulates the stability of beta-catenin. Oncogene 18, 849\u2013854, https:\/\/doi.org\/10.1038\/sj.onc.1202653 (1999).","journal-title":"Oncogene"},{"key":"56208_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1152\/physrev.00012.2016","volume":"97","author":"N Foot","year":"2017","unstructured":"Foot, N., Henshall, T. & Kumar, S. Ubiquitination and the Regulation of Membrane Proteins. Physiol Rev 97, 253\u2013281, https:\/\/doi.org\/10.1152\/physrev.00012.2016 (2017).","journal-title":"Physiol Rev"},{"key":"56208_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/jcp.20694","volume":"209","author":"G Swaminathan","year":"2006","unstructured":"Swaminathan, G. & Tsygankov, A. Y. The Cbl family proteins: ring leaders in regulation of cell signaling. J Cell Physiol 209, 21\u201343, https:\/\/doi.org\/10.1002\/jcp.20694 (2006).","journal-title":"J Cell Physiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56208-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56208-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56208-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T13:06:05Z","timestamp":1671282365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56208-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,27]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["56208"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-56208-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,27]]},"assertion":[{"value":"22 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20257"}}